NL
DE
Hans de Wilt received a Dutch Cancer Society Grant of 625K euros for the STARTREC trial. The STARTREC trail is an international trial for patients with early cancer in the distal rectum
These patients can undergo complete resection of the rectum, including all lymph nodes with a high chance of cure (90-95%), but also with a high risk for a permanent colostomy. In this trial patients can either undergo this treatment or will be randomized for one of two organ preservation arms. This means treatment with radiation therapy or chemoradiation therapy and no or limited surgery in case of a good clinical response. The number of organ preservation and quality of life differences between the different treatment arms will be some of the end points of this trial. This might lead to a paradigm shift in the treatment of rectal cancer.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Increased role of patients after bowel cancer treatment
30 July 2020 Approximately 14,000 patients get colorectal cancer every year. Almost all patients are operated on and monitored afterwards (follow-up). In 2019 Radboudumc started a new approach to follow-up research after the treatment of stage II/III colorectal cancer. read more
Laparoscopy reduces the number of adhesions but it is still too high
14 January 2020 Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues. read more
Secure trial usual care to a restrictive patient selection for gallbladder surgery
23 May 2019 In Lancet Kees van Laarhoven and colleagues showed that usual care for gallstone patients is suboptimal and that less than two third of patients are pain-free after surgery. read more
Valentine’s day spectacle at the Radboud Research Rounds
21 February 2019 This year’s Valentine’s day in the Radboudumc was focused on the RRR of the Tumors of the Digestive Tract. In the biannual Paper Award session the big prize went to Daniel Garza from the Center for Molecular and Biomolecular Informatics, for his paper on “the environmental metabolome”. read more
Radiotherapy-associated angiosarcoma after breast cancer treatment
7 February 2019 In Jama Oncology Anouk Rombouts and co-workers showed that one in 1000 patients who were treated with radiotherapy for breast cancer will develop an angiosarcoma of the breast. read more
